Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
Fiche publication
Date publication
novembre 2022
Journal
The oncologist
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CONROY Thierry
Tous les auteurs :
Yeh C, Zhou M, Sigel K, Jameson G, White R, Safyan R, Saenger Y, Hecht E, Chabot J, Schreibman S, Juzyna B, Ychou M, Conroy T, Fojo T, Manji GA, Von Hoff D, Bates SE
Lien Pubmed
Résumé
Methods for screening agents earlier in development and strategies for conducting smaller randomized controlled trials (RCTs) are needed.
Mots clés
pancreatic cancer, survival biomarkers, tumor growth rate
Référence
Oncologist. 2022 11 11;: